STUDI PENGGUNAAN PHOSPHATE BINDER PADA PASIEN CKD (CHRONIC KIDNEY DISEASE) (Penelitian dilakukan di Instalasi Rawat Inap (IRNA) RSUD Dr. Iskak Tulungagung)
Daftar Isi:
- Background: Chronic Kidney Disease (CKD) is a structural abnormality or renal function disorder that occurs for three months or more. Hyperphosphatemia is a developmental form of CKD that usually occurs in the third stage of a disease. The effect of hyperphosphatemia is a bone mineral disorder and tissue calcification. Phosphate binder is one of the therapies that can be used in overcoming hyperphosphatemia. The mechanism work is by binding the phosphate in the intestine and secreted with the feces so that the phosphate is not absorbed in the body Objective: To know the pattern of phosphate binder usage in CKD patient at hospitalization service Dr. Iskak district general hospital of Tulungagung Method: An observational retrospective. The presentation data used is descriptive data of the RMK data CKD patients hospitalized in the period Juli to December 2017. Result and Conclusion: Phosphate binder was only used singly, 130 patients (77%) used calcium carbonate, 11 patients (7%) used calcium acetate, and switched in 27 patients (16%). The most regimentation of calcium carbonate (3x500mg) PO dosage in 121 patients (62%), while on calcium acetate (1x169mg) PO as many as 16 patients (8%).